CTI BIOPHARMA CORP Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cti Biopharma Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q1 2023.
  • Cti Biopharma Corp Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $1.89M, a 32.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $1.89M -$893K -32.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.08M -$1.03M -33.2% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 $2.26M +$1.16M +104% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $2.36M +$894K +60.9% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $2.78M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $3.11M +$960K +44.7% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $1.11M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.47M Jun 30, 2021 10-Q 2021-08-05
Q4 2020 $2.15M -$1.23M -36.4% Dec 31, 2020 10-K 2022-03-31
Q1 2020 $3.09M -$880K -22.2% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $3.38M -$829K -19.7% Dec 31, 2019 10-K 2021-03-17
Q3 2019 $3.45M Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $3.72M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $3.97M Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $4.21M Jan 1, 2019 10-K 2020-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.